Home › Research › Prevention and risk
Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis
Antoine Meyer, Simon S. M. Chan, Mathilde Touvier, Chantal Julia, Anne Marie Tjønneland, Cecilie Kyrø, Christina Catherine Dahm, Verena Andrea Katzke et al.. Alimentary Pharmacology & Therapeutics, 2025-01-16
Topic: Risk, prevention and care in population studies
We included 394,255 individuals including 184 incident cases of CD and 459 of UC after median follow-up of 13.6 years (4,889,910 person-years). High ISD scores were associated with a higher risk of CD (fourth vs. first quartile-adjusted HR: 1.88, 95% CI: 1.14-3.10; p-trend < 0.01) but not of UC (adjusted HR: 0.85, 95% CI: 0.63-1.15; p-trend 0.21). For CD, this association was mainly observed for women (adjusted HR: 2.14, 95% CI: 1.17-3.91; p-trend < 0.01). On subgroup analyses, those differences were mainly driven by low intakes of fibre, mono-unsaturated fatty acids, vitamin C, magnesium, onion and alcohol. A high ISD score is associated with a higher risk of developing CD but not UC. These results should be taken into account in high-risk populations.
Key findings
- We included 394,255 individuals including 184 incident cases of CD and 459 of UC after median follow-up of 13.6 years (4,889,910 person-years).
- High ISD scores were associated with a higher risk of CD (fourth vs. first quartile-adjusted HR: 1.88, 95% CI: 1.14-3.10; p-trend < 0.01) but not of UC (adjusted HR: 0.85, 95% CI: 0.63-1.15; p-trend 0.21).
- For CD, this association was mainly observed for women (adjusted HR: 2.14, 95% CI: 1.17-3.91; p-trend < 0.01).
- On subgroup analyses, those differences were mainly driven by low intakes of fibre, mono-unsaturated fatty acids, vitamin C, magnesium, onion and alcohol.
- A high ISD score is associated with a higher risk of developing CD but not UC.
Why it matters
This cohort study found that a high inflammatory diet score was associated with higher risk of Crohn's disease but not ulcerative colitis. It provides no information on Alzheimer's disease.
New to this subject? Start with our plain-English guide: Prevention →
Study details
- Participants394,255
- Effect sizeHR: 1.88; HR: 0.85; HR: 2.14
- Evidence strengthModerate
How this study scored 58/100
Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alimentary Pharmacology & Therapeutics) |
| Journal's citation record | 2 / 4 | Alimentary Pharmacology & Therapeutics: journal h-index 246 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 394,255 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 17 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 9.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 2 / 4 | Cited 17 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Aurélien Amiot: h-index 43 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Oxford: institution h-index 2,205 (OpenAlex) |
| Multi-centre collaboration | 3 / 3 | OpenAlex lists 28 institution(s) in 6 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39817326) |
| Free to read | 2 / 2 | Free to read |
| Total | 58 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1111/apt.18497
- PubMed: 39817326
- Original source →
- Free full text: UEA Digital Repository (University of East Anglia) →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
APA 7th
Meyer, A., Chan, S. S. M., Touvier, M., Julia, C., Tjønneland, A. M., Kyrø, C., et al. (2025). Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18497
Vancouver
Meyer A, Chan SSM, Touvier M, Julia C, Tjønneland AM, Kyrø C, et al. Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18497. PMID: 39817326.
BibTeX
@article{meyer2025-39817326,
author = {Meyer, Antoine and Chan, Simon S. M. and Touvier, Mathilde and Julia, Chantal and Tjønneland, Anne Marie and Kyrø, Cecilie and Dahm, Christina Catherine and Katzke, Verena Andrea and others},
title = {{Inflammatory Potential of the Diet and Risk of Crohn's Disease and Ulcerative Colitis}},
journal = {Alimentary Pharmacology \& Therapeutics},
year = {2025},
doi = {10.1111/apt.18497},
pmid = {39817326},
url = {https://doi.org/10.1111/apt.18497}
}
Related studies in Prevention and risk
Also in Prevention and risk
265 studies in the library are filed under Prevention and risk with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Prevention and risk hub.